Anika Therapeutics, Inc., (NASDAQ: ANIK) announced that the U.S. Food & Drug Administration’s (FDA) Office of Combination Products has assigned ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE